The short version
- Why people research itParathyroid function and calcium handling — bone health from the hormonal side.
- What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
- What to watchFlank pain in waves with blood in urine, a stone from extra urinary calcium.
How Bonothyrk works
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
Khavinson-school organ peptide extracts. The claim is tissue specificity: a short peptide fraction from one organ is proposed to act on that same organ, restoring its protein synthesis toward a younger pattern by binding regulatory DNA sequences. The mechanism is coherent and the human evidence for it is thin outside the group that proposed it. The parathyroid governs calcium handling, which is why this sits alongside the bone bioregulators.
- Oral
On the goal map: Bone remodeling — building vs preserving (Joints & bone)
Research on Bonothyrk4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Theoretical — Khavinson-school work, largely Russian-language and rarely replicated outside it.
Human clinical evidence
No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
No completed human trial
Correlative data
The Khavinson group reported improvements in organ-specific markers across a long series of studies from the 1980s onward. These are overwhelmingly small, single-arm, and published in Russian-language journals; independent replication outside that school is close to absent.
How the mechanism reads
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
MechanisticOral delivery is the open question, not the mechanism. Peptides are poorly absorbed intact from the gut. Whether enough survives to reach the target tissue has not been shown in a way anyone outside the manufacturer can check.
Mechanistic
Sources
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Khavinson VKh. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine 2012 · PMID 22808515
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Khavinson VK. Tissue-specific effects of peptides. Bulletin of Experimental Biology and Medicine 2001;132(2):807-808 · PMID 11713572
Bonothyrk safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Hyperparathyroidism or high blood calcium.
- A history of kidney stones, since parathyroid signaling raises urinary calcium.
- Hypoparathyroidism on calcium or vitamin D replacement.
- Pregnancy or breastfeeding, while calcium is tightly regulated.
What’s expected
- No acute sensation has been described.
- If it acts on parathyroid tissue, the signal would appear in calcium and PTH, not in how you feel.
- Occasional mild stomach upset.
Watch for
- Flank pain in waves with blood in urine, a stone from extra urinary calcium.
- Tingling around the mouth or muscle cramps, low calcium signs.
- New bone pain or fractures from minor force.
Labs that tell you it’s working
- Parathyroid Hormone & Calcium: the direct target organ output.
- Vitamin D (25-Hydroxy): drives PTH secretion, so read them together.
- Magnesium: low levels blunt PTH release and mimic parathyroid failure.
- Osteocalcin: shows whether bone turnover shifted.
Khavinson-school parathyroid peptide fraction proposed to act on that same organ's gene expression; the safety question is calcium and PTH. PMID 26390619 PMID 11713572
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Bonothyrk FAQ4 common questions
- Is Bonothyrk approved for human use?
- No. Bonothyrk is a research compound. No completed randomized human trial has given it yet.
- What is Bonothyrk researched for?
- Parathyroid function and calcium handling — bone health from the hormonal side.
- Which labs show whether it's doing anything?
- Parathyroid Hormone & Calcium; Vitamin D; Magnesium; Osteocalcin: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Bonothyrk: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



